Sublytic C5b-9 Induces CCL3/4 Production and Macrophage Accumulation in Thy-1N Rats via PKC-α/p65/IRF-8 Axis

Wenbo Wang1, Baomei Qian1, Chenhui Zhao2

  • 1Department of Immunology, and Key Laboratory of Immunological Environment and Disease, Nanjing Medical University, Nanjing, Jiangsu 211166, China.

Insights

Sublytic C5b-9 triggers kidney inflammation and macrophage accumulation in mesangioproliferative glomerulonephritis (MsPGN) by activating the PKC-α/p65/IRF-8 pathway, leading to increased CCL3/4 production and disease progression.

Area of Science:

  • Nephrology
  • Immunology
  • Molecular Biology

Background:

  • Mesangioproliferative glomerulonephritis (MsPGN) is a common kidney disease.
  • Rat Thy-1 nephritis (Thy-1N) is a key animal model for studying MsPGN, involving complement component C5b-9, inflammation, and macrophage infiltration.

Purpose of the Study:

  • To elucidate the molecular mechanisms by which sublytic C5b-9 induces inflammation and macrophage accumulation in MsPGN.
  • To investigate the role of the PKC-α/p65/IRF-8 signaling axis in regulating chemokine production and macrophage recruitment in MsPGN.

Main Methods:

  • Utilized both *in vivo* (Thy-1N rat model) and *in vitro* (glomerular mesangial cells) approaches.
  • Assessed the expression and phosphorylation of key proteins (PKC-α, NF-κB-p65, IRF-8) and chemokines (CCL3/4).
  • Employed gene knockdown techniques to determine the functional significance of identified molecules in disease pathogenesis.

Main Results:

  • Sublytic C5b-9 stimulation upregulated PKC-α, p65, IRF-8, and CCL3/4 expression in renal tissues and glomerular mesangial cells.
  • PKC-α activation promoted p65 phosphorylation, which in turn enhanced IRF-8 expression.
  • IRF-8 directly regulated CCL3/4 transcription, driving macrophage chemotaxis and accumulation; gene knockdown ameliorated disease markers.

Conclusions:

  • Sublytic C5b-9 activates the PKC-α/p65/IRF-8 signaling pathway, leading to CCL3/4 production and macrophage accumulation in MsPGN.
  • This pathway is a critical driver of MsPGN pathogenesis, contributing to glomerular mesangial cell proliferation and proteinuria.
  • Targeting this axis represents a potential therapeutic strategy for managing MsPGN.

Related Concept Videos